electroCore (ECOR) Cash from Investing Activities (2017 - 2026)
electroCore's (ECOR) quarterly Cash from Investing Activities came in at $597000.0 in Q1 2026, down 86.73% year-on-year from $4.5 million in Q1 2025, and up 15.25% quarter-over-quarter from $518000.0 in Q4 2025.
electroCore (ECOR) Cash from Investing Activities (2017 - 2026) Analysis & Trends
electroCore's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at $597000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 86.73% year-over-year to $597000.0 in Q1 2026; TTM through Mar 2026 was -$26000.0, a 80.3% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 145.51% from the prior year.
- Cash from Investing Activities improved to $597000.0 in Q1 2026 per ECOR's latest filing, from $518000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $4.5 million in Q1 2025 and bottomed at -$4.1 million in Q3 2024.
- The 4-year median for Cash from Investing Activities is -$41000.0 (2023), against an average of -$25777.8.
- Across the five-year window, Cash from Investing Activities plunged 5427.03% in 2024 and soared 203.39% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$41000.0 in 2023, then tumbled by 1121.95% to -$501000.0 in 2024, then surged by 203.39% to $518000.0 in 2025, then grew by 15.25% to $597000.0 in 2026.
- Per Business Quant, the three latest ECOR Cash from Investing Activities figures stand at $597000.0 (Q1 2026), $518000.0 (Q4 2025), and -$1.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | electroCore | 55,642.90 | -8.77 Mn | 8.36 Mn | 597,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 597,000.00 |
| Mar 31, 2026 | 597,000.00 |
| Dec 31, 2025 | 518,000.00 |
| Dec 31, 2025 | 518,000.00 |
| Sep 30, 2025 | -1.33 Mn |
| Sep 30, 2025 | -1.33 Mn |
| Jun 30, 2025 | 185,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | -501,000.00 |
| Dec 31, 2024 | -501,000.00 |
| Sep 30, 2024 | -4.09 Mn |
| Sep 30, 2024 | -4.09 Mn |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | -74,000.00 |
| Sep 30, 2023 | -74,000.00 |
| Dec 31, 2021 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |